Clinical Trial Update: Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer [Phase 1]

View source ↗

Summary

The document reports completion of a Phase 1 open-label trial assessing the safety of OPB-51602 in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• OPB-51602 (OPB-51602)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED